Skinvisible (SKVI) Operating Expenses (2010 - 2026)

Skinvisible has disclosed Operating Expenses across 17 years of filings, most recently posting $130938.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $130938.0, down 9.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $502401.0 (down 19.78% YoY), and the FY2025 annual result was $516315.0, down 15.3% from the prior year.
• Operating Expenses came in at $130938.0 for Q1 2026 at Skinvisible, up from $119169.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $203743.0 in Q4 2024 to a low of $111057.0 in Q3 2025.
• The 5-year median for Operating Expenses is $130938.0 (2026), against an average of $134125.7.
• Across the five-year window, Operating Expenses jumped 43.95% in 2024 and sank 41.51% in 2025, its largest moves.
• Skinvisible's Operating Expenses stood at $122716.0 in 2022, then grew by 15.34% to $141538.0 in 2023, then surged by 43.95% to $203743.0 in 2024, then sank by 41.51% to $119169.0 in 2025, then climbed by 9.88% to $130938.0 in 2026.
• The last three Operating Expenses figures came in at $130938.0 (Q1 2026), $119169.0 (Q4 2025), and $111057.0 (Q3 2025), per Business Quant data.